Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

from The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts · host Learn Advocate Connect Neuroendocrine Tumor Society

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.For more information, visit LACNETS.org/podcast/24. For more information, visit NCF.net.

Episode metadata supplied by the publisher feed · Published Sep 15, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

0:00 45:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts?

This episode is 45 minutes long.

When was this The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts episode published?

This episode was published on September 15, 2023.

Can I download this The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!